In this article, James M. Dupree, MD, MPH; Maddie Jones; and Christopher M. Gonzalez, MD, MBA explain what constitutes an accountable care organization and how a urologist might (or might not) interact with one.
Hormone therapy plus current treatments improves survival in prostate cancer
March 23rd 2023Darolutamide increased overall survival compared to placebo in the overall patient population and patients with high-volume, high-risk mHSPC as well as in patients with low-risk metastatic hormone-sensitive prostate cancer.
2 Clarke Drive
Cranbury, NJ 08512